In a phase 2 trial, called NOBILITY, obinutuzumab plus standard therapies outperformed standard therapies alone. The results of the phase 3 trial, REGENCY, were published on February 7 ...
Neumora halted one trial of its depression drug navacaprant and paused a pair of late-stage studies as it tries to learn from ...
Discover the latest experimental obesity drug from Novo Nordisk, achieving 15.7% weight loss after 68 weeks, which fell short of the company's expectations.
Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company, today announced positive topline results from its ...
(RTTNews) - Acurx Pharmaceuticals, Inc. (ACXP) Monday announced that its lead antibiotic candidate, ibezapolstat, is advancing to international Phase 3 clinical trials for treating C. difficile ...
Amgen (AMGN) and AstraZeneca (AZN) announced full results from the Phase 3, registrational WAYPOINT trial demonstrating that TEZSPIRE ...
VERITAC-2 achieved its primary endpoint in the estrogen receptor 1-mutant population, demonstrating statistically significant and clinically ...
Independent interim analysis of the E.mbrace phase 3 study finds that the vaccine candidate ... Janssen Research & Development, LLC, is the trial sponsor and responsible party and will continue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback